全文获取类型
收费全文 | 5616篇 |
免费 | 434篇 |
国内免费 | 1篇 |
专业分类
6051篇 |
出版年
2023年 | 28篇 |
2022年 | 65篇 |
2021年 | 124篇 |
2020年 | 60篇 |
2019年 | 81篇 |
2018年 | 108篇 |
2017年 | 94篇 |
2016年 | 159篇 |
2015年 | 276篇 |
2014年 | 269篇 |
2013年 | 360篇 |
2012年 | 453篇 |
2011年 | 424篇 |
2010年 | 267篇 |
2009年 | 216篇 |
2008年 | 330篇 |
2007年 | 326篇 |
2006年 | 304篇 |
2005年 | 295篇 |
2004年 | 261篇 |
2003年 | 253篇 |
2002年 | 260篇 |
2001年 | 63篇 |
2000年 | 58篇 |
1999年 | 66篇 |
1998年 | 68篇 |
1997年 | 54篇 |
1996年 | 37篇 |
1995年 | 45篇 |
1994年 | 39篇 |
1993年 | 43篇 |
1992年 | 43篇 |
1991年 | 40篇 |
1990年 | 39篇 |
1989年 | 40篇 |
1988年 | 21篇 |
1987年 | 14篇 |
1986年 | 15篇 |
1985年 | 29篇 |
1984年 | 19篇 |
1983年 | 14篇 |
1982年 | 34篇 |
1981年 | 21篇 |
1980年 | 16篇 |
1979年 | 19篇 |
1978年 | 14篇 |
1976年 | 18篇 |
1975年 | 13篇 |
1973年 | 20篇 |
1972年 | 15篇 |
排序方式: 共有6051条查询结果,搜索用时 0 毫秒
101.
102.
Freddy Sitas Alison Gibberd Clare Kahn Marianne F. Weber May Chiew Rajah Supramaniam Louiza Velentzis Carolyn Nickson David P. Smith Dianne O’Connell Megan A. Smith Katie Armstrong Xue Qin Yu Karen Canfell Monica Robotin Eleonora Feletto Andrew Penman 《Cancer epidemiology》2013,37(6):780-787
BackgroundAustralia has one of the highest rates of cancer incidence worldwide and, despite improving survival, cancer continues to be a major public health problem. Our aim was to provide simple summary measures of changes in cancer mortality and incidence in Australia so that progress and areas for improvement in cancer control can be identified.MethodsWe used national data on cancer deaths and newly registered cancer cases and compared expected and observed numbers of deaths and cases diagnosed in 2007. The expected numbers were obtained by applying 1987 age–sex specific rates (average of 1986–1988) directly to the 2007 population. The observed numbers of deaths and incident cases were calculated for 2007 (average of 2006–2008). We limited the analyses to people aged less than 75 years.ResultsThere was a 28% fall in cancer mortality (7827 fewer deaths in 2007 vs. 1987) and a 21% increase in new cancer diagnoses (13,012 more diagnosed cases in 2007). The greatest reductions in deaths were for cancers of the lung in males (?2259), bowel (?1797), breast (?773) and stomach (?577). Other notable falls were for cancers of the prostate (?295), cervix (?242) and non-Hodgkin lymphoma (?240). Only small or no changes occurred in mortality for cancers of the lung (female only), pancreas, brain and related, oesophagus and thyroid, with an increase in liver cancer (267). Cancer types that showed the greatest increase in incident cases were cancers of the prostate (10,245), breast (2736), other cancers (1353), melanoma (1138) and thyroid (1107), while falls were seen for cancers of the lung (?1705), bladder (?1110) and unknown primary (?904).ConclusionsThe reduction in mortality indicates that prevention strategies, improvements in cancer treatment, and screening programmes have made significant contributions to cancer control in Australia since 1987. The rise in incidence is partly due to diagnoses being brought forward by technological improvements and increased coverage of screening and early diagnostic testing. 相似文献
103.
Monica Rolando Serena Sanulli Christophe Rusniok Laura Gomez-Valero Clement Bertholet Tobias Sahr Raphael Margueron Carmen Buchrieser 《Cell host & microbe》2013,13(4):395-405
Highlights? Upon infection, L. pneumophila secretes RomA, a SET domain-containing methyltransferase ? RomA triggers H3K14 trimethylation, causing a switch from gene activation to repression ? ChIP-seq identified 4,870 H3K14 methylated promoter regions, including innate immune genes ? RomA SET domain is required for efficient intracellular replication of L. pneumophila 相似文献
104.
Casandra W. Philipson Josep Bassaganya-Riera Monica Viladomiu Mireia Pedragosa Richard L. Guerrant James K. Roche Raquel Hontecillas 《PloS one》2013,8(2)
Background
Enteroaggregative Escherichia coli (EAEC) is recognized as an emerging cause of persistent diarrhea and enteric disease worldwide. Mucosal immunity towards EAEC infections is incompletely understood due in part to the lack of appropriate animal models. This study presents a new mouse model and investigates the role of peroxisome proliferator-activated receptor gamma (PPARγ) in the modulation of host responses to EAEC in nourished and malnourished mice.Methods/Principal Findings
Wild-type and T cell-specific PPARγ null C57BL/6 mice were fed protein-deficient diets at weaning and challenged with 5×109cfu EAEC strain JM221 to measure colonic gene expression and immune responses to EAEC. Antigen-specific responses to E. coli antigens were measured in nourished and malnourished mice following infection and demonstrated the immunosuppressive effects of malnutrition at the cellular level. At the molecular level, both pharmacological blockade and deletion of PPARγ in T cells resulted in upregulation of TGF-β, IL-6, IL-17 and anti-microbial peptides, enhanced Th17 responses, fewer colonic lesions, faster clearance of EAEC, and improved recovery. The beneficial effects of PPARγ blockade on weight loss and EAEC clearance were abrogated by neutralizing IL-17 in vivo.Conclusions
Our studies provide in vivo evidence supporting the beneficial role of mucosal innate and effector T cell responses on EAEC burden and suggest pharmacological blockade of PPARγ as a novel therapeutic intervention for EAEC infection. 相似文献105.
106.
107.
108.
Linnea B?rebring Maria Bullarbo Anna Glantz Monica Leu Agelii ?se Jagner Joy Ellis Lena Hulthén Inez Schoenmakers Hanna Augustin 《PloS one》2016,11(3)
Every tenth pregnancy is affected by hypertension, one of the most common complications and leading causes of maternal death worldwide. Hypertensive disorders in pregnancy include pregnancy-induced hypertension and preeclampsia. The pathophysiology of the development of hypertension in pregnancy is unknown, but studies suggest an association with vitamin D status, measured as 25-hydroxyvitamin D (25(OH)D). The aim of this study was to investigate the association between gestational 25(OH)D concentration and preeclampsia, pregnancy-induced hypertension and blood pressure trajectory. This cohort study included 2000 women. Blood was collected at the first (T1) and third (T3) trimester (mean gestational weeks 10.8 and 33.4). Blood pressure at gestational weeks 10, 25, 32 and 37 as well as symptoms of preeclampsia and pregnancy-induced hypertension were retrieved from medical records. Serum 25(OH)D concentrations (LC-MS/MS) in T1 was not significantly associated with preeclampsia. However, both 25(OH)D in T3 and change in 25(OH)D from T1 to T3 were significantly and negatively associated with preeclampsia. Women with a change in 25(OH)D concentration of ≥30 nmol/L had an odds ratio of 0.22 (p = 0.002) for preeclampsia. T1 25(OH)D was positively related to T1 systolic (β = 0.03, p = 0.022) and T1 diastolic blood pressure (β = 0.02, p = 0.016), and to systolic (β = 0.02, p = 0.02) blood pressure trajectory during pregnancy, in adjusted analyses. There was no association between 25(OH)D and pregnancy-induced hypertension in adjusted analysis. In conclusion, an increase in 25(OH)D concentration during pregnancy of at least 30 nmol/L, regardless of vitamin D status in T1, was associated with a lower odds ratio for preeclampsia. Vitamin D status was significantly and positively associated with T1 blood pressure and gestational systolic blood pressure trajectory but not with pregnancy-induced hypertension. 相似文献
109.
Christina S. Polyak Krista Yuhas Benson Singa Monica Khaemba Judd Walson Barbra A. Richardson Grace John-Stewart 《PLoS medicine》2016,13(1)
Background
Cotrimoxazole (CTX) prophylaxis is recommended by the World Health Organization (WHO) for HIV-1-infected individuals in settings with high infectious disease prevalence. The WHO 2006 guidelines were developed prior to the scale-up of antiretroviral therapy (ART). The threshold for CTX discontinuation following ART is undefined in resource-limited settings.Methods and Findings
Between 1 February 2012 and 30 September 2013, we conducted an unblinded non-inferiority randomized controlled trial of CTX prophylaxis cessation versus continuation among HIV-1-infected adults on ART for ≥18 mo with CD4 count > 350 cells/mm3 in a malaria-endemic region in Kenya. Participants were randomized and followed up at 3-mo intervals for 12 mo. The primary endpoint was a composite of morbidity (malaria, pneumonia, and diarrhea) and mortality. Incidence rate ratios (IRRs) were estimated using Poisson regression.Among 538 ART-treated adults screened, 500 were enrolled and randomized, 250 per arm. Median age was 40 y, 361 (72%) were women, and 442 (88%) reported insecticide-treated bednet use. Combined morbidity/mortality was significantly higher in the CTX discontinuation arm (IRR = 2.27, 95% CI 1.52–3.38; p < 0.001), driven by malaria morbidity. There were 34 cases of malaria, with 33 in the CTX discontinuation arm (IRR = 33.02, 95% CI 4.52–241.02; p = 0.001). Diarrhea and pneumonia rates did not differ significantly between arms (IRR = 1.36, 95% CI 0.82–2.27, and IRR = 1.43, 95% CI 0.54–3.75, respectively). Study limitations include a lack of placebo and a lower incidence of morbidity events than expected.Conclusions
CTX discontinuation among ART-treated, immune-reconstituted adults in a malaria-endemic region resulted in increased incidence of malaria but not pneumonia or diarrhea. Malaria endemicity may be the most relevant factor to consider in the decision to stop CTX after ART-induced immune reconstitution in regions with high infectious disease prevalence. These data support the 2014 WHO CTX guidelines.Trial registration
ClinicalTrials.gov NCT01425073相似文献110.
Antonia Barcelo Josep Miquel Bau?a Aina Ya?ez Laura Fueyo Cristina Gomez Monica de la Pe?a Javier Pierola Alberto Rodriguez Manuel Sanchez-de-la-Torre Jorge Abad Olga Mediano Jose Amilibia Maria Jose Masdeu Joaquin Teran Josep Maria Montserrat Mercè Mayos Alicia Sanchez-de-la-Torre Ferran Barbé Spanish Sleep Group 《PloS one》2016,11(3)